Clinical trial
Un-fractionated Heparin Versus Bivalirudin During Percutaneous Coronary…
NCT00262054 · Deutsches Herzzentrum Muenchen, Other · Completed
Key facts
| NCT number | NCT00262054 |
|---|---|
| Title | Un-fractionated Heparin Versus Bivalirudin During Percutaneous Coronary Interventions (PCI) (ISAR-REACT-3) |
| Official title | Prospective, Randomized, Double-Blind, Active-Controlled, Multicenter Trial of Bivalirudin and Un-fractionated Heparin in Patients Undergoing Percutaneous Coronary Interventions. ISAR-REACT-3 |
| Lead sponsor | Deutsches Herzzentrum Muenchen, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Coronary Disease, Angina Pectoris |
| Intervention type | Drug |
| Interventions | Bivalirudin, Un-fractionated heparin |
| Enrollment | 4,570 |
| Start date | Nov 1, 2005 |
| Primary completion | Feb 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Dec 6, 2005 |
| Last update posted | Mar 15, 2010 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: